Beschreibung
This title provides an illuminating examination of the current state of xenotransplantation grafting or transplanting organs or tissues between members of different species and how it might move forward into the clinic. To be sure, this is a critical topic, as a major problem that remains worldwide is an inadequate supply of organs from deceased human donors, severely limiting the number of organ transplants that can be performed each year. Based on presentations given at a major conference on xenotransplantation, this title includes important views from many leading experts who were invited to present their data and opinions on how xenotransplantation can advance into the clinic. Attention was concentrated on pig kidney and heart transplantation as it is in regard to these organs that most progress has been made. Collectively, these chapters effectively highlight the many advantages of xenotransplantation to patients with end-stage organ failure, thereby encouraging the mapping of a concrete pathway to clinical xenotransplantation.
The book is organized across 22 chapters, beginning with background information on clinical and experimental xenotransplantation. Following this are discussions addressing how pigs can be genetically engineered for their organs to be resistant to the human immune response through deletion of pig xenoantigens, and the insertion of protective human transgenes. Subsequent chapters analyze complications that arise in practice, comparing allotransplant and xenotransplant rejection. The selection of the ideal patients for the first clinical trials is discussed. Finally, the book concludes with an analysis on the regulatory, economic, and social aspects of this research, including FDA perspectives and the sensitive, psychosocial factors regarding allotransplantation and xenotransplantation.
A major and timely addition to the literature, Clinical Xenotransplantation will be of great interest to all researchers, physicians, and academics from other disciplines with an interest in xenotransplantation.
Autorenportrait
David K.C. Cooper MD, PhD, FRCSUniversity of Alabama at Birmingham (UAB)Co-Director, Xenotransplantation ProgramDepartment of SurgeryBirmingham, AL
Guerard W. Byrne, PhDDepartment of SurgeryUniversity of Alabama at BirminghamBirmingham, ALUSA
Inhalt
Clinical and Experimental Xenotransplantation: Background.- 1. A brief history of clinical cross-species organ xenotransplantation.- 2. The pathobiology of pig-to-primate xenotransplantation: a historical review.- 3. Is sensitization to pig antigens detrimental to subsequent allotransplantation?.- 4. Sensitization to human leukocyte antigens and xenotransplantation?.- Pig Kidney and Heart Xenotransplantation in Nonhuman Primates the Present Position.- 5. Kidney xenotransplantation in nonhuman primates.- 6. Cardiac xenotransplantation in nonhuman primates.- Organ-source Pig Genetic Engineering and Regulation.- 7. Gene-edited pigs for xenotransplantation.- 8. Addressing regulatory requirements for the organ-source pig a pragmatic approach to facility design and pathogen prevention.- Antibody-Mediated Allotransplant Rejection: Lessons for Xenotransplantation.- 9. Antibody-mediated graft rejection in nonhuman primate models: comparison of sensitized allotransplant and xenotransplant rejection.- 10. Management of anti-HLA antibodies and acute antibody-mediated rejection.- 11. Evolving approaches to treatment of allosensitization and antibody-mediated rejection.- 12. Lessons from ABO-incompatible cardiac allotransplantation in the newborn.- Patient Evaluation and Selection for First Clinical Trials of Kidney or Heart Xenotransplantation.- 13. Defining an acceptable risk threshold who should be the first kidney xenotransplant recipient?.- 14. Selection of patients for initial clinical trials of kidney xenotransplantation.- 15. Selection of patients for initial clinical trials of cardiac xenotransplantation.- 16. Selection of pediatric patients for initial clinical trials of cardiac xenotransplantation.- 17. Infection in xenotransplantation: organ-source health and patient safety.- 18. Histocompatibility testing for xenotransplantation.- Regulatory, Economic, and Social Aspects of Clinical Trials of Xenotransplantation.- 19. Xenotransplantation; the FDA perspective.- 20. Xenotransplantation: a payers perspective.- 21. Public perceptions towards clinical trials of organ xenotransplantation.- Summation.- 22. What did the workshop achieve?
Informationen zu E-Books
Herzlichen Glückwunsch zum Kauf eines Ebooks bei der BUCHBOX! Hier nun ein paar praktische Infos.
Adobe-ID
Hast du E-Books mit einem Kopierschutz (DRM) erworben, benötigst du dazu immer eine Adobe-ID. Bitte klicke einfach hier und trage dort Namen, Mailadresse und ein selbstgewähltes Passwort ein. Die Kombination von Mailadresse und Passwort ist deine Adobe-ID. Notiere sie dir bitte sorgfältig.
Achtung: Wenn du kopiergeschützte E-Books OHNE Vergabe einer Adobe-ID herunterlädst, kannst du diese niemals auf einem anderen Gerät außer auf deinem PC lesen!!
Lesen auf dem Tablet oder Handy
Wenn du auf deinem Tablet lesen möchtest, verwende eine dafür geeignete App.
Für iPad oder Iphone etc. hole dir im iTunes-Store die Lese-App Bluefire
Lesen auf einem E-Book-Reader oder am PC / MAC
Um die Dateien auf deinen PC herunter zu laden und auf dein E-Book-Lesegerät zu übertragen gibt es die Software ADE (Adobe Digital Editions).
Andere Geräte / Software
Kindle von Amazon. Wir empfehlen diese Geräte NICHT.
EPUB mit Adobe-DRM können nicht mit einem Kindle von Amazon gelesen werden. Weder das Dateiformat EPUB, noch der Kopierschutz Adobe-DRM sind mit dem Kindle kompatibel. Umgekehrt können alle bei Amazon gekauften E-Books nur auf dem Gerät von Amazon gelesen werden. Lesegeräte wie der Tolino sind im Gegensatz hierzu völlig frei: Du kannst bei vielen tausend Buchhandlungen online Ebooks für den Tolino kaufen. Zum Beispiel hier bei uns.
Software für Sony-E-Book-Reader
Computer/Laptop mit Unix oder Linux
Die Software Adobe Digital Editions ist mit Unix und Linux nicht kompatibel. Mit einer WINE-Virtualisierung kommst du aber dennoch an deine E-Books.